Canada markets close in 13 minutes

Syngen Biotech Co.,Ltd. (8279.TWO)

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
Add to watchlist
153.00-2.00 (-1.29%)
At close: 01:18PM CST
Currency in TWD

Valuation Measures4

Market Cap (intraday) 4.20B
Enterprise Value 4.47B
Trailing P/E 16.08
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.26
Price/Book (mrq)2.04
Enterprise Value/Revenue 2.40
Enterprise Value/EBITDA 10.47

Trading Information

Stock Price History

Beta (5Y Monthly) 0.43
52-Week Change 3-16.44%
S&P500 52-Week Change 326.16%
52 Week High 3191.50
52 Week Low 3148.00
50-Day Moving Average 3156.16
200-Day Moving Average 3158.80

Share Statistics

Avg Vol (3 month) 38.24k
Avg Vol (10 day) 36.6k
Shares Outstanding 527.1M
Implied Shares Outstanding 627.19M
Float 8N/A
% Held by Insiders 165.92%
% Held by Institutions 12.79%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 45
Forward Annual Dividend Yield 43.23%
Trailing Annual Dividend Rate 35.00
Trailing Annual Dividend Yield 33.23%
5 Year Average Dividend Yield 41.46
Payout Ratio 451.87%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 29, 2023
Last Split Factor 21100:1000
Last Split Date 3Jul 09, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 14.96%
Operating Margin (ttm)15.46%

Management Effectiveness

Return on Assets (ttm)6.13%
Return on Equity (ttm)13.33%

Income Statement

Revenue (ttm)1.84B
Revenue Per Share (ttm)67.79
Quarterly Revenue Growth (yoy)-10.30%
Gross Profit (ttm)N/A
EBITDA 386.21M
Net Income Avi to Common (ttm)274.83M
Diluted EPS (ttm)9.61
Quarterly Earnings Growth (yoy)-17.10%

Balance Sheet

Total Cash (mrq)366.89M
Total Cash Per Share (mrq)13.54
Total Debt (mrq)538.49M
Total Debt/Equity (mrq)25.26%
Current Ratio (mrq)1.94
Book Value Per Share (mrq)78.65

Cash Flow Statement

Operating Cash Flow (ttm)415.13M
Levered Free Cash Flow (ttm)248.24M